Case Presentation
The resident was admitted following a swing bed hospitalization. On admission, the resident required stand-by assistance and could ambulate only 10–15 feet. Symptoms included insomnia, confusion, and daytime restlessness. Medication orders included Ambien (zolpidem) PRN at bedtime and Trazodone PRN at bedtime.
The Approach
The resident’s individualized plan of care focused on medication oversight, symptom monitoring, structured daily routine, and consistent provider communication. Ambien (zolpidem) was discontinued due to adverse effects, and Trazodone 100 mg was scheduled nightly. Laboratory testing was initiated due to persistent confusion and restlessness, revealing anemia, and the resident received an iron infusion to address the underlying condition. Just as importantly, establishing a consistent daily schedule—including regular meals, therapy, and meaningful activities—helped restore a healthy sleep–wake cycle, which played a significant role in stabilizing insomnia and reducing nighttime disruption.



The Progress
Following medication adjustment, treatment of anemia, and implementation of a structured daily routine, the resident demonstrated measurable improvement. Ambulation progressed from 10–15 feet with stand-by assistance to independently walking to meals with a walker. Sleep stabilized, cognitive clarity improved, and daytime agitation decreased.
Life Today
It took approximately one month to fully stabilize the resident’s condition. One month later, the resident is alert, oriented, calm, and actively participating in daily social engagements. Strength, endurance, and functional mobility significantly improved.
Why This Matters
This case demonstrates the clinical role of assisted living in medication management, early symptom recognition, and coordinated intervention—resulting in improved stability and restored function.
Disclaimer: Care details shared in this case study are based on a Morning Pointe resident. In keeping with HIPAA guidelines, the resident’s name and identifying information are not disclosed.



